Abstract
The 2019 Corona virus Outbreak (COVID-19) is a scientific, medical and social challenge. The complexity of Severe Acute Respiratory Syndrome Corona virus 2 (SARSCoV2) focuses on the clinical course of unpredictable illnesses that can develop rapidly and cause serious complications leading to death. Systemic inflammation and lung problems can ensue, causing considerable morbidity and mortality. Acute coronary syndrome (ACS), arrhythmias, myocarditis, acute myocardial damage, heart failure, and other problems affect the cardiovascular system. Existing data about cardiovascular complications had been collected from the case study performed in China, Wuhan, and New York COVID-19 patients. In the case report of China, 16.7% out of 138 patients showed arrhythmias where heart failure was identified as a problem in 23% of patients in a retrospective study from Wuhan and 52% of non-survivors in China. On the other hand case studies on 18 COVID-19 patients with ST-elevation myocardial infarction (STEMI) on electrocardiogram (ECG) from New York were investigated; 6 patients (33%) reported chest pain, 14 patients (78%) reported ST-segment elevation, 6 patients (35%) reported regional wall motion abnormality on TTE, and 8 patients (44%) reported a clinical diagnosis of myocardial infarction and a total of 9 patients individuals (50%) had coronary angiography, with 6 patients (67%) of them showing obstructive disease. The cardiovascular consequences of COVID-19 infection are examined in this brief paper. The virus attaches to ACE2 (Angiotensin converting enzyme 2), allowing it to enter. COVID-19 therapy is currently being studied in conjunction with cardiovascular drugs. Therefore, emergency phy
Highlights
The 2019 Corona virus Outbreak (COVID-19) is a scientific, medical and social challenge
Secondary cardiac invasion is commonly caused by systemic inflammatory syndrome and may be manifested in acute myocardial damage/ elevated biomarkers and / or heart failure (CHF)
A systemic inflammatory condition can cause seconddary cardiac involvement, which can appear as acute myocardial damage, biomarker increase, and/or heart failure (CHF)
Summary
The 2019 Corona virus Outbreak (COVID-19) is a scientific, medical and social challenge. The complexity of Severe Acute Respiratory Syndrome Corona virus 2 (SARSCoV2) focuses on the clinical course of unpredictable illnesses that can develop rapidly and cause serious complications leading to death. Acute coronary syndrome (ACS), arrhythmias, myocarditis, acute myocardial damage, heart failure, and other problems affect the cardiovascular system. Existing data about cardiovascular complications had been collected from the case study performed in China, Wuhan and New York COVID-19 patients. COVID-19 can cause terrifying pulmonary complications such as Rahman et al, / European Journal of Medical and Health Sciences, 3(5), 116-122, 2021 acute respiratory distress syndrome, as well as acute myocardial damage and dysfunction, which can promote or contribute to shock and manifold organ failure. Secondary cardiac invasion is commonly caused by systemic inflammatory syndrome and may be manifested in acute myocardial damage/ elevated biomarkers and / or heart failure (CHF). Additional vascular complications of COVID19 disease are identified and described (Dan et al, 2020)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have